Journal article
Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson’s disease brain
BG Trist, KM Davies, V Cottam, S Genoud, R Ortega, S Roudeau, A Carmona, K De Silva, V Wasinger, SJG Lewis, P Sachdev, B Smith, C Troakes, C Vance, C Shaw, S Al-Sarraj, HJ Ball, GM Halliday, DJ Hare, KL Double
Acta Neuropathologica | SPRINGER | Published : 2017
Abstract
Neuronal loss in numerous neurodegenerative disorders has been linked to protein aggregation and oxidative stress. Emerging data regarding overlapping proteinopathy in traditionally distinct neurodegenerative diseases suggest that disease-modifying treatments targeting these pathological features may exhibit efficacy across multiple disorders. Here, we describe proteinopathy distinct from classic synucleinopathy, predominantly comprised of the anti-oxidant enzyme superoxide dismutase-1 (SOD1), in the Parkinson’s disease brain. Significant expression of this pathology closely reflected the regional pattern of neuronal loss. The protein composition and non-amyloid macrostructure of these novel..
View full abstractGrants
Awarded by National Institutes of Health
Funding Acknowledgements
This work was supported by funds from the Australian Research Council, the National Health and Medical Research Council of Australia (NHMRC), Parkinson's NSW (2015 and 2016 seed grants), and the University of Sydney (Biomedical Science, BRIG).